TP53 and colonic neoplasm: We demonstrate potent antiproliferative activity of CCT020312 at low μmolar concentrations, which is detectable in both p53 positive (HCT116) and p53 negative (HT29) human colon cancer cells and remains considerable even under conditions of time-limited exposure to the compound.